scholarly article | Q13442814 |
P356 | DOI | 10.1023/A:1019806411610 |
P698 | PubMed publication ID | 12240946 |
P2093 | author name string | Ashim K Mitra | |
Banmeet S Anand | |||
P2860 | cites work | Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization | Q24317726 |
Drug transport and targeting. Intestinal transport. | Q33878819 | ||
Transporter-mediated permeation of drugs across the blood-brain barrier | Q34051724 | ||
Membrane transporters | Q34061174 | ||
Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2. | Q34121835 | ||
Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2 | Q34298240 | ||
Determination of acid surface pH in vivo in rat proximal jejunum | Q34496469 | ||
Acyclovir transport by the human placenta | Q34542399 | ||
Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers | Q34729029 | ||
Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue | Q35812095 | ||
Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic Efficacy | Q40138670 | ||
Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line | Q40763033 | ||
Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. | Q40877910 | ||
Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line | Q40965871 | ||
Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2. | Q41010097 | ||
Carrier-mediated intestinal transport of drugs | Q41140046 | ||
Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs | Q43938182 | ||
Mechanism of acyclovir uptake in rat jejunum | Q44153379 | ||
Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. | Q48068970 | ||
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir | Q48932058 | ||
The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine | Q48953363 | ||
Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells. | Q50719104 | ||
Acyclovir in the treatment of herpetic stromal disease | Q70664270 | ||
How peptides cross biological membranes | Q70973750 | ||
Effect of acylation on the ocular disposition of acyclovir. I: Synthesis, physicochemical properties, and antiviral activity of 2'-esters | Q72238878 | ||
Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis | Q72238880 | ||
Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution | Q73073421 | ||
The influence of luminal pH on transport of neutral and charged dipeptides by rat small intestine, in vitro | Q73202090 | ||
Characterization of an oligopeptide transporter in renal lysosomes | Q73822227 | ||
Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells | Q73891025 | ||
Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter | Q77357223 | ||
P433 | issue | 8 | |
P921 | main subject | aciclovir | Q147101 |
P304 | page(s) | 1194-1202 | |
P577 | publication date | 2002-08-01 | |
P1433 | published in | Pharmaceutical Research | Q7180737 |
P1476 | title | Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea | |
P478 | volume | 19 |
Q38995367 | A comprehensive insight on ocular pharmacokinetics |
Q38904119 | Advances in the use of prodrugs for drug delivery to the eye. |
Q44856650 | Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium |
Q53594005 | Biotin uptake by rabbit corneal epithelial cells: role of sodium-dependent multivitamin transporter (SMVT). |
Q39218343 | Characterization of the carrier-mediated transport of ketoprofen, a nonsteroidal anti-inflammatory drug, in rabbit corneal epithelium cells |
Q36527751 | Chemical modification and formulation approaches to elevated drug transport across cell membranes |
Q39647814 | Cinnamic esters of acyclovir-synthesis and biological activity |
Q34779782 | Current prodrug strategies via membrane transporters/receptors |
Q47578401 | Diclofenac/biodegradable polymer micelles for ocular applications |
Q46399484 | Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies |
Q34141933 | Evaluation of active and passive transport processes in corneas extracted from preserved rabbit eyes |
Q44483643 | Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of acyclovir and idoxuridine |
Q46799578 | Identification and characterization of a Na+-dependent neutral amino acid transporter, ASCT1, in rabbit corneal epithelial cell culture and rabbit cornea |
Q53592834 | Identification and functional expression of a carrier-mediated riboflavin transport system on rabbit corneal epithelium. |
Q36573373 | Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues |
Q37850457 | In vitro cell culture models to study the corneal drug absorption |
Q43298355 | Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment |
Q36903801 | Novel approaches to retinal drug delivery |
Q37103787 | Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity |
Q44483641 | Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea |
Q38065184 | Novel strategies for anterior segment ocular drug delivery |
Q26851574 | Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition |
Q30475605 | Ocular drug delivery |
Q42105578 | Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections |
Q39557119 | Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir |
Q36316835 | Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters |
Q42170327 | Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats |
Q36939218 | Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. |
Q35950189 | Prodrug approach to improve absorption of prednisolone |
Q38005228 | Prodrug strategies in ocular drug delivery |
Q37256549 | Recent perspectives in ocular drug delivery |
Q40941028 | Small Neutral Amino Acid Ester Prodrugs of Acyclovir Targeting Amino Acid Transporters on the Cornea: Possible Antiviral Agents Against Ocular HSV-1 Infections |
Q44466742 | Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir |
Q39332407 | Targeted lipid based drug conjugates: a novel strategy for drug delivery. |
Q51937395 | Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. |
Q37147862 | Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement |
Q45004828 | Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB(0,+). |
Q35116134 | Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies |
Q35990861 | mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs |